Literature DB >> 9598219

Does ADHD affect the course of substance abuse? Findings from a sample of adults with and without ADHD.

T E Wilens1, J Biederman, E Mick.   

Abstract

The authors examined the effects of attention-deficit hyperactivity disorder (ADHD) and psychiatric comorbidity on recovery from psychoactive substance use disorder (PSUD) with 130 referred adults with ADHD and 71 non-ADHD adults, all of whom had a lifetime history of PSUD. Although PSUD remitted in 80% of both groups, the rate of remission and duration of PSUD was quite different in the ADHD vs. non-ADHD subjects. The duration of PSUD was 37.2 months longer in the ADHD than in non-ADHD subjects. The median time to PSUD remission was more than twice as long in ADHD than in control subjects (144 vs. 60 months, respectively). ADHD is associated with a longer, duration of PSUD and a significantly slower remission rate. If confirmed, such findings extend previous work showing that ADHD is a risk factor for early initiation and specific pathways of PSUD, providing further evidence of the relevance of this association.

Entities:  

Mesh:

Year:  1998        PMID: 9598219

Source DB:  PubMed          Journal:  Am J Addict        ISSN: 1055-0496


  38 in total

1.  Methylphenidate transdermal system in adults with past stimulant misuse: an open-label trial.

Authors:  Aimee L McRae-Clark; Kathleen T Brady; Karen J Hartwell; Kathleen White; Rickey E Carter
Journal:  J Atten Disord       Date:  2010-06-10       Impact factor: 3.256

Review 2.  Understanding attention-deficit/hyperactivity disorder from childhood to adulthood.

Authors:  Timothy E Wilens; Thomas J Spencer
Journal:  Postgrad Med       Date:  2010-09       Impact factor: 3.840

3.  Extended-release medications for children and adolescents with attention-deficit hyperactivity disorder.

Authors:  M Feldman; S Bélanger
Journal:  Paediatr Child Health       Date:  2009-11       Impact factor: 2.253

Review 4.  Psychotherapy of adults with comorbid attention-deficit/hyperactivity disorder and psychoactive substance use disorder.

Authors:  R B Aviram; M Rhum; F R Levin
Journal:  J Psychother Pract Res       Date:  2001

Review 5.  Substance abuse in patients with attention-deficit hyperactivity disorder : therapeutic implications.

Authors:  Howard Schubiner
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

6.  Screened Attention Deficit/Hyperactivity Disorder as a Predictor of Substance Use Initiation and Escalation in Early Adulthood and the Role of Self-Reported Conduct Disorder and Sensation Seeking: A 5-Year Longitudinal Study with Young Adult Swiss Men.

Authors:  Franz Moggi; Deborah Schorno; Leila Maria Soravia; Meichun Mohler-Kuo; Natialia Estévez-Lamorte; Joseph Studer; Gerhard Gmel
Journal:  Eur Addict Res       Date:  2020-06-19       Impact factor: 3.015

Review 7.  Assessment and management of attention-deficit hyperactivity disorder in adults.

Authors:  Margaret Weiss; Candice Murray
Journal:  CMAJ       Date:  2003-03-18       Impact factor: 8.262

8.  Impulsivity and its Relationship to Risky Sexual Behaviors and Drug Abuse.

Authors:  Ken C Winters; Andria M Botzet; Tamara Fahnhorst; Lindsey Baumel; Susanne Lee
Journal:  J Child Adolesc Subst Abuse       Date:  2009-01-01

Review 9.  European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD.

Authors:  Sandra J J Kooij; Susanne Bejerot; Andrew Blackwell; Herve Caci; Miquel Casas-Brugué; Pieter J Carpentier; Dan Edvinsson; John Fayyad; Karin Foeken; Michael Fitzgerald; Veronique Gaillac; Ylva Ginsberg; Chantal Henry; Johanna Krause; Michael B Lensing; Iris Manor; Helmut Niederhofer; Carlos Nunes-Filipe; Martin D Ohlmeier; Pierre Oswald; Stefano Pallanti; Artemios Pehlivanidis; Josep A Ramos-Quiroga; Maria Rastam; Doris Ryffel-Rawak; Steven Stes; Philip Asherson
Journal:  BMC Psychiatry       Date:  2010-09-03       Impact factor: 3.630

Review 10.  Treatment strategies for co-occurring ADHD and substance use disorders.

Authors:  John J Mariani; Frances R Levin
Journal:  Am J Addict       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.